(CRBG) Corebridge Financial - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US21871X1090
Stock:
Total Rating 15
Risk 57
Buy Signal -0.93
| Risk 5d forecast | |
|---|---|
| Volatility | 46.0% |
| Relative Tail Risk | -2.24% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.65 |
| Alpha | -45.02 |
| Character TTM | |
|---|---|
| Beta | 1.320 |
| Beta Downside | 1.789 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.11% |
| CAGR/Max DD | 0.54 |
EPS (Earnings per Share)
Revenue
Description: CRBG Corebridge Financial
Corebridge Financial, Inc. provides retirement solutions and insurance products in the United States. The company operates through Individual Retirement, Group Retirement, Life Insurance, and Institutional Markets segments. The Individual Retirement segment provides fixed annuities, fixed index and registered index-linked, and variable annuities. The Group Retirement segment offers in-plan products and services comprising an open architecture recordkeeping platform that allows plan participants to allocate money to a variety of mutual fund options or a fixed interest account; flexible group variable and fixed annuity; and in-plan investment advisory services. It also provides out-of-plan products and services, including proprietary and non-proprietary annuities; investment advisory solutions, such as fiduciary, fee-based investments; and brokerage services for non-proprietary variable annuity, securities, life insurance, mutual funds, and 529 plans. The Life Insurance segment offers term, whole, index universal, and guaranteed universal life insurance products. The Institutional Markets segment provides defined contribution and bank-owned life insurance stable value wraps, structured settlement and pension risk transfer annuities, corporate and bank-owned life insurance, private placement variable universal life and annuities products, and guaranteed investment contracts. The company was formerly known as SAFG Retirement Services, Inc. Corebridge Financial, Inc. was incorporated in 1998 and is headquartered in Houston, Texas.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: -366.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.06 > 1.0 |
| NWC/Revenue: 1507 % < 20% (prev 2372 %; Δ -865.1% < -1%) |
| CFO/TA 0.00 > 3% & CFO 2.02b > Net Income -366.0m |
| Net Debt (10.46b) to EBITDA (567.0m): 18.45 < 3 |
| Current Ratio: 2.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (512.1m) vs 12m ago -10.32% < -2% |
| Gross Margin: 80.89% > 18% (prev 0.79%; Δ 8010 % > 0.5%) |
| Asset Turnover: 0.72% > 50% (prev 0.69%; Δ 0.03% > 0%) |
| Interest Coverage Ratio: 0.02 > 6 (EBITDA TTM 567.0m / Interest Expense TTM 552.0m) |
Altman Z'' 0.86
| A: 0.11 (Total Current Assets 67.19b - Total Current Liabilities 23.65b) / Total Assets 413.55b |
| B: 0.04 (Retained Earnings 18.37b / Total Assets 413.55b) |
| C: 0.00 (EBIT TTM 11.0m / Avg Total Assets 401.47b) |
| D: 0.02 (Book Value of Equity 8.93b / Total Liabilities 399.59b) |
| Altman-Z'' Score: 0.86 = B |
Beneish M
| DSRI: 0.84 (Receivables 648.0m/713.0m, Revenue 2.89b/2.68b) |
| GMI: 0.98 (GM 80.89% / 79.31%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.08 (Revenue 2.89b / 2.68b) |
| TATA: -0.01 (NI -366.0m - CFO 2.02b) / TA 413.55b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of CRBG shares?
As of March 04, 2026, the stock is trading at USD 25.10 with a total of 3,799,263 shares traded.
Over the past week, the price has changed by -8.83%, over one month by -16.64%, over three months by -14.45% and over the past year by -24.37%.
Over the past week, the price has changed by -8.83%, over one month by -16.64%, over three months by -14.45% and over the past year by -24.37%.
Is CRBG a buy, sell or hold?
Corebridge Financial has received a consensus analysts rating of 4.07.
Therefore, it is recommended to buy CRBG.
- StrongBuy: 6
- Buy: 5
- Hold: 2
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CRBG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 37.5 | 49.6% |
| Analysts Target Price | 37.5 | 49.6% |
CRBG Fundamental Data Overview February 28, 2026
P/E Forward = 5.9916
P/S = 0.7556
P/B = 1.4248
Revenue TTM = 2.89b USD
EBIT TTM = 11.0m USD
EBITDA TTM = 567.0m USD
Long Term Debt = 10.91b USD (from longTermDebt, last quarter)
Short Term Debt = 9.36b USD (from shortTermDebt, last quarter)
Debt = 10.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.46b USD (from netDebt column, last quarter)
Enterprise Value = -41.57b USD (14.07b + Debt 10.91b - CCE 66.54b)
Interest Coverage Ratio = 0.02 (Ebit TTM 11.0m / Interest Expense TTM 552.0m)
EV/FCF = -20.57x (Enterprise Value -41.57b / FCF TTM 2.02b)
FCF Yield = -4.86% (FCF TTM 2.02b / Enterprise Value -41.57b)
FCF Margin = 69.96% (FCF TTM 2.02b / Revenue TTM 2.89b)
Net Margin = -12.67% (Net Income TTM -366.0m / Revenue TTM 2.89b)
Gross Margin = 80.89% ((Revenue TTM 2.89b - Cost of Revenue TTM 552.0m) / Revenue TTM)
Gross Margin QoQ = 81.67% (prev 81.35%)
Tobins Q-Ratio = -0.10 (set to none) (Enterprise Value -41.57b / Total Assets 413.55b)
Interest Expense / Debt = 1.21% (Interest Expense 132.0m / Debt 10.91b)
Taxrate = 17.82% (173.0m / 971.0m)
NOPAT = 9.04m (EBIT 11.0m * (1 - 17.82%))
Current Ratio = 2.84 (Total Current Assets 67.19b / Total Current Liabilities 23.65b)
Debt / Equity = 0.83 (Debt 10.91b / totalStockholderEquity, last quarter 13.20b)
Debt / EBITDA = 18.45 (Net Debt 10.46b / EBITDA 567.0m)
Debt / FCF = 5.18 (Net Debt 10.46b / FCF TTM 2.02b)
Total Stockholder Equity = 12.76b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.09% (Net Income -366.0m / Total Assets 413.55b)
RoE = -2.87% (Net Income TTM -366.0m / Total Stockholder Equity 12.76b)
RoCE = 0.05% (EBIT 11.0m / Capital Employed (Equity 12.76b + L.T.Debt 10.91b))
RoIC = 0.04% (NOPAT 9.04m / Invested Capital 24.03b)
WACC = 6.51% (E(14.07b)/V(24.97b) * Re(10.78%) + D(10.91b)/V(24.97b) * Rd(1.21%) * (1-Tc(0.18)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.06%
[DCF] Terminal Value 83.10% ; FCFF base≈2.07b ; Y1≈1.95b ; Y5≈1.82b
[DCF] Fair Price = 72.83 (EV 45.54b - Net Debt 10.46b = Equity 35.08b / Shares 481.7m; r=6.51% [WACC]; 5y FCF grow -7.79% → 2.90% )
EPS Correlation: -31.14 | EPS CAGR: -32.65% | SUE: 0.13 | # QB: 0
Revenue Correlation: 15.59 | Revenue CAGR: 15.17% | SUE: -2.75 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.28 | Chg7d=-0.014 | Chg30d=-0.008 | Revisions Net=-1 | Analysts=12
EPS current Year (2026-12-31): EPS=5.16 | Chg7d=-0.056 | Chg30d=-0.075 | Revisions Net=-7 | Growth EPS=+16.6% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=5.99 | Chg7d=-0.064 | Chg30d=-0.154 | Revisions Net=-7 | Growth EPS=+16.1% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)
P/S = 0.7556
P/B = 1.4248
Revenue TTM = 2.89b USD
EBIT TTM = 11.0m USD
EBITDA TTM = 567.0m USD
Long Term Debt = 10.91b USD (from longTermDebt, last quarter)
Short Term Debt = 9.36b USD (from shortTermDebt, last quarter)
Debt = 10.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.46b USD (from netDebt column, last quarter)
Enterprise Value = -41.57b USD (14.07b + Debt 10.91b - CCE 66.54b)
Interest Coverage Ratio = 0.02 (Ebit TTM 11.0m / Interest Expense TTM 552.0m)
EV/FCF = -20.57x (Enterprise Value -41.57b / FCF TTM 2.02b)
FCF Yield = -4.86% (FCF TTM 2.02b / Enterprise Value -41.57b)
FCF Margin = 69.96% (FCF TTM 2.02b / Revenue TTM 2.89b)
Net Margin = -12.67% (Net Income TTM -366.0m / Revenue TTM 2.89b)
Gross Margin = 80.89% ((Revenue TTM 2.89b - Cost of Revenue TTM 552.0m) / Revenue TTM)
Gross Margin QoQ = 81.67% (prev 81.35%)
Tobins Q-Ratio = -0.10 (set to none) (Enterprise Value -41.57b / Total Assets 413.55b)
Interest Expense / Debt = 1.21% (Interest Expense 132.0m / Debt 10.91b)
Taxrate = 17.82% (173.0m / 971.0m)
NOPAT = 9.04m (EBIT 11.0m * (1 - 17.82%))
Current Ratio = 2.84 (Total Current Assets 67.19b / Total Current Liabilities 23.65b)
Debt / Equity = 0.83 (Debt 10.91b / totalStockholderEquity, last quarter 13.20b)
Debt / EBITDA = 18.45 (Net Debt 10.46b / EBITDA 567.0m)
Debt / FCF = 5.18 (Net Debt 10.46b / FCF TTM 2.02b)
Total Stockholder Equity = 12.76b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.09% (Net Income -366.0m / Total Assets 413.55b)
RoE = -2.87% (Net Income TTM -366.0m / Total Stockholder Equity 12.76b)
RoCE = 0.05% (EBIT 11.0m / Capital Employed (Equity 12.76b + L.T.Debt 10.91b))
RoIC = 0.04% (NOPAT 9.04m / Invested Capital 24.03b)
WACC = 6.51% (E(14.07b)/V(24.97b) * Re(10.78%) + D(10.91b)/V(24.97b) * Rd(1.21%) * (1-Tc(0.18)))
Discount Rate = 10.78% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -10.06%
[DCF] Terminal Value 83.10% ; FCFF base≈2.07b ; Y1≈1.95b ; Y5≈1.82b
[DCF] Fair Price = 72.83 (EV 45.54b - Net Debt 10.46b = Equity 35.08b / Shares 481.7m; r=6.51% [WACC]; 5y FCF grow -7.79% → 2.90% )
EPS Correlation: -31.14 | EPS CAGR: -32.65% | SUE: 0.13 | # QB: 0
Revenue Correlation: 15.59 | Revenue CAGR: 15.17% | SUE: -2.75 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.28 | Chg7d=-0.014 | Chg30d=-0.008 | Revisions Net=-1 | Analysts=12
EPS current Year (2026-12-31): EPS=5.16 | Chg7d=-0.056 | Chg30d=-0.075 | Revisions Net=-7 | Growth EPS=+16.6% | Growth Revenue=+4.3%
EPS next Year (2027-12-31): EPS=5.99 | Chg7d=-0.064 | Chg30d=-0.154 | Revisions Net=-7 | Growth EPS=+16.1% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: -0.33 (1 Up / 2 Down within 30d for Next Quarter)